Background: Most thyroid nodules are benign and do not need intervention. Toxic adenoma and toxic multinodular goiter (MNG) are common causes of hyperthyroidism, second in prevalence only to Graves' disease. Toxic adenoma and MNG are the result of focal or diff use hyperplasia of thyroid follicular cells whose functional capacity is independent from regulation by the thyroid stimulating hormone (TSH). When conservative treatment modalities fail to ensure an euthyroid state, surgical intervention is required, typically surgical left or right thyroid lobectomy. Radiofrequency ablation (RFA) is a new percutaneous treatment option that results in thermal tissue necrosis and fi brosis. As a result of this process, the thyroid nodules shrink. Case presentation: We describe a case of a young woman with a large toxic thyroid adenoma who refused surgery. She was admitted to a one-day surgery unit and underwent radiofrequency ablation under total intravenous anesthesia. Using "moving shot technique" the procedure went uneventfully and the toxic adenoma displayed a signifi cant volume reduction with resolution of the hyperthyroid symptoms. The patient also reported a signifi cant improvement of her neck symptoms (from 7/10 to 1/10 on a Visual Analogue Scale). Conclusions: Radiofrequency ablation is a new, well tolerated, safe and eff ective treatment option in selected patients with benign thyroid nodules, toxic adenomas of the thyroid gland and multinodular goiter. To the best of our knowledge, this is the fi rst time such treatment modality is used in Bulgaria.
INTRODUCTION
M ost thyroid nodules are benign and do not need intervention [1] . However, some thyroid nodules are associated with progressive growth and may result in compressive symptoms and cosmetic concerns that might require intervention -typically thyroid surgery. Radiofrequency ablation (RFA) is a percutaneous treatment that results in thermal tissue necrosis and fi brosis [1, 2] . Clinical trials demonstrated between 30 and 80% reduction in thyroid nodule volume, durable shrinkage and improvement of neck compression symptoms in patients after thyroid RFA [2] [3] [4] [5] .
CASE PRESENTATION
A 38-years-old woman discovered the presence of a mass on neck palpation. Her family history indicated an absence of thyroid illnesses, and she disclosed no past medical history. The patient was an offi ce worker who did not live in an iodine-poor area, and reported having a good dietary intake of iodine. She neither smoked, nor drunk alcohol and was not taking any medication. Her vital parameters: body mass index (BMI), blood pressure, heart rate and temperature were normal (BMI 21,4 kg/m 2 ; BP 100/65 mm Hg; HR 74 beats/min and t 36,4°C, respectively). A physical examination confi rmed the presence of a soft-elastic mass in the right portion of her neck which was mobile on swallowing. The patient underwent an ultrasound (US) scan, which showed a large, single, structurally heterogenic and anisoechoic nodule with dimensions: anteroposterior × laterolateral × craniocaudal diameters 35 × 40 × 45 mm, respectively, located in the right lobe of the thyroid gland and exhibiting increased blood fl ow. The patient also experienced some neck discomfort. Her score was 7-8/10 on a Visual analog scale. Laboratory tests revealed a hyperthyroid state (TSH concentration of 0, 01 mIU/L). The 99mTc SPECT CT scan ( Figure 1 ) revealed a toxic adenoma in the right thyroid lobe. The patient was given thyrostatic medication and later underwent a fi ne-needle aspiration biopsy (FNAB) with evacuation of about 10 ml dark colloid content, the cytological evaluation of which revealed Bethesda II -a benign nodule [3] . The procedure was well tolerated by the patient and no adverse events were noted. After completion of the procedure, the patient was awaked and transferred to a post-anesthesia unit. The sides of fi ne needle entrypoints were visible on the skin of the patient's neck until 5-th post-procedural day. The patient experienced no complains and was discharged from the hospital on the next day (well below 23-hours in-hospital stay) in a self-reporting perfect condition with prescription of TSH control after 2 months. Over the next thirty days, the patient reported a progressive improvement of her neck symptoms and cosmetic complains. She was followed-up by US scan until the fi rst month, when marked, visible and progressive (Figure 3 ) reduction of nodule size was achieved. The patient's thyroid function was still slightly hyperthyroid but with a tendency to normalization  TSH 0, 19 mIU/L. 
DISCUSSION
To the best of our knowledge, this is the fi rst description in Bulgaria of the eff ect of minimally invasive percutaneous ablative technique performed in a patient with a toxic adenoma of the thyroid gland, as an alternative treatment option to surgery. We report a case of a young woman who underwent RFA for the treatment of large toxic adenoma in the right thyroid lobe, after refusing right thyroidectomy. RFA has been off ered to patients with large (≥ 3 cm), predominantly solid thyroid nodules [4] [5] [6] 9] that demonstrated growth or were causing compressive symptoms and cosmetic concerns. The therapeutic success cut-off edge for minimally-invasive radiofrequency ablative techniques is defi ned as nodule volume reduction > 50% [4] [5] [6] 11] . Some factors that might predict a RFA therapeutic success, though these are controversial are: small volume (< 10 ml) of the nodule at baseline [9] , the absence of vascularization [10] , nonfunctioning status [2] , the presence of fl uid and well-defi ned margins [2, [7] [8] [9] . In our patient, the thyroid nodule volume was large (> 13 ml), the adenoma was autonomously functioning (toxic adenoma) with marked vascularization but had well-defi ned margins and contained colloid fl uid component inside; thus, making the value of these predictive factors questionable. Additional studies should be conducted in similar patient populations with a particular focus on factors predicting greater response to RFA and comparing the performance of RFA with other procedures.
CONCLUSION
Ultrasound-guided radiofrequency ablation for thyroid lesions is a well-tolerated, minimally invasive treatment modality with a good effi cacy and safety profi le that might be an alternative to conventional surgery in patients with thyroid nodules. It is a useful tool for the management of related cosmetic complains and pressure symptoms as well as a valuable option for the treatment of hyperactive thyroid toxic nodules in patients refusing surgery.
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